The dosages below are from completed studies on humans or on clinical trials on humans. In general, they represent safe dosages for most people. Please be aware that there is often an exponentail effectiveness. Talking half the dosage may only see 1/4 of the effect. We are not looking at minimum effective dosage, but maximum [safe] dosage used in clinical trials and studies.
If a study has been completed, the dosage will be marked Ineffective or Effective -- depending if statistically changes were reported by the study.
This is not medical advice (see your MD for that). It is a reporting on dosages that some MDs have used.
| Study | Clinical Study | Dosage | Effective |
|---|---|---|---|
| . | COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes (COVID-FIS) | 20 mg/kg/day | |
| . | COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation | 20 mg/kg/day | |
| . | Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women (AFFIRM) | 20 mg/kg/day | |
| . | Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Adults (AFFIRM-LITE) | 20 mg/kg/day | |
| . | Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis | 20 mg/kg/day |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2022 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.